Delivery Order SPE2DB20D1100-SPE2DB23FD7C4

Award Date 9/19/23
Potential Completion Date 9/20/23
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,031.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4554605384 - Trileptal 300 mg tablets in 100-count bottles. The award is a firm-fixed-price delivery order contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at one thousand seven hundred thirty-seven dollars and seventy-eight cents ($1,737.78) by the Defense Logistics Agency (DLA) to supply one hundred (100) Trileptal 300 mg tablets in support of DLA Troop Support Medical programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by October 27, 2023. No set-aside designation was applied to...
This federal contract award, valued at $7,004.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Trileptal 300 mg tablets, a medication used to treat seizure disorders. The contract is a Firm Fixed Price Delivery Order with a completion date of May 14, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and the company is a subsidiary of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.43, is for the delivery of Trileptal 300 mg/5 ml suspension, a pharmaceutical product, with a completion date of January 31, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.10 firm fixed-price delivery order is for the supply of Trileptal 300mg/5ml suspension, a medication used to treat epilepsy. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,079.45 firm-fixed-price delivery order is for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.25 Firm Fixed Price Delivery Order is for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $3,283.70 for the supply of Trileptal 300 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,668.30 Firm Fixed Price contract is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. This is a Delivery Order under the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the supply of Trileptal 300 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $10,177.84 and an ultimate completion date of September 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a major pharmaceutical distribution company serving the U.S. federal government, particularly the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FD7C4
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,052.32 contract is for the procurement of 4,562,235,883 units of the medication Trileptal 300 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/12/25, 10:47 AM